Subscribe
24 June 2025NewsCareersMuireann Bolger

Boies Schiller Flexner adds three-strong litigation team

Trio have worked together for several years at different firms, bringing decades of experience in medical devices, robotics, and life sciences.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Japanese firm adds ex-Norvartis and Alnylam in-house counsel
19 June 2025   Former in-house counsel at major pharma companies brings expertise in IP strategy, regulatory compliance, and business development across pharma and biotech.
Careers
McDermott Will & Emery appoints senior Paris litigator
17 June 2025   Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving supplementary protection certificates and second medical use claims.
Careers
Sheppard Mullin expands practice with Perkins Coie trio
12 June 2025   Three seasoned lawyers with experience in biotech, pharmaceutical, and medical device patent matters join the firm's practice in Washington, DC and Chicago offices.


Editor's picks

A step too far? Why Stewart’s approach is dividing opinion
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

Editor's picks

Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025

More on this story

Careers
Japanese firm adds ex-Norvartis and Alnylam in-house counsel
19 June 2025   Former in-house counsel at major pharma companies brings expertise in IP strategy, regulatory compliance, and business development across pharma and biotech.
Careers
McDermott Will & Emery appoints senior Paris litigator
17 June 2025   Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving supplementary protection certificates and second medical use claims.
Careers
Sheppard Mullin expands practice with Perkins Coie trio
12 June 2025   Three seasoned lawyers with experience in biotech, pharmaceutical, and medical device patent matters join the firm's practice in Washington, DC and Chicago offices.

More on this story

Careers
Japanese firm adds ex-Norvartis and Alnylam in-house counsel
19 June 2025   Former in-house counsel at major pharma companies brings expertise in IP strategy, regulatory compliance, and business development across pharma and biotech.
Careers
McDermott Will & Emery appoints senior Paris litigator
17 June 2025   Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving supplementary protection certificates and second medical use claims.
Careers
Sheppard Mullin expands practice with Perkins Coie trio
12 June 2025   Three seasoned lawyers with experience in biotech, pharmaceutical, and medical device patent matters join the firm's practice in Washington, DC and Chicago offices.

More features

AstraZeneca forced to clarify deal terms in row with university
Novartis loses cancer drug patent following Teva challenge at EPO
A step too far? Why Stewart’s approach is dividing opinion
WATCH: Section 112—Where has the dust settled?
UPC rejects Alexion’s rehearing bid in spat with Amgen and Samsung
Biotech seeks to stop Kirkland from representing rival in Eylea dispute
Regeneron hits Amgen over its blockbuster eye disease treatment
Japanese firm adds ex-Norvartis and Alnylam in-house counsel